Hypoxaemia in patients with heart failure and preserved ejection fraction

被引:6
|
作者
Omar, Massar [1 ,2 ,3 ]
Omote, Kazunori [1 ]
Sorimachi, Hidemi [1 ]
Popovic, Dejana [1 ]
Kanwar, Ardaas [4 ]
Alogna, Alessio [1 ]
Reddy, Yogesh N. V. [1 ]
Lim, Kaiser G. [5 ]
Shah, Sanjiv J. [6 ]
Borlaug, Barry A. [1 ]
机构
[1] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
[2] Odense Univ Hosp, Dept Cardiol, Odense, Denmark
[3] Odense Univ Hosp, Steno Diabet Ctr Odense, Odense, Denmark
[4] Univ Minnesota, Minneapolis, MN USA
[5] Mayo Clin, Dept Pulm & Crit Care Med, Rochester, MN USA
[6] Northwestern Univ, Div Cardiol, Dept Med, Feinberg Sch Med, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
Heart failure with preserved ejection fraction; Invasive cardiopulmonary exercise test; Hypoxaemia; Gas analysis; Outcome; PULMONARY-HYPERTENSION; EXERCISE PERFORMANCE; DIFFUSING-CAPACITY; INSPIRED OXYGEN; LUNG-FUNCTION; GAS-EXCHANGE; ULTRAFILTRATION; VENTILATION; DYSFUNCTION; CONGESTION;
D O I
10.1002/ejhf.2930
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims It is widely held that heart failure (HF) does not cause exertional hypoxaemia, based upon studies in HF with reduced ejection fraction, but this may not apply to patients with HF and preserved ejection fraction (HFpEF). Here, we characterize the prevalence, pathophysiology, and clinical implications of exertional arterial hypoxaemia in HFpEF Methods and results Patients with HFpEF (n=539) and no coexisting lung disease underwent invasive cardiopulmonary exercise testing with simultaneous blood and expired gas analysis. Exertional hypoxaemia (oxyhaemoglobin saturation <94%) was observed in 136 patients (25%). As compared to those without hypoxaemia (n=403), patients with hypoxaemia were older and more obese. Patients with HFpEF and hypoxaemia had higher cardiac filling pressures, higher pulmonary vascular pressures, greater alveolar-arterial oxygen difference, increased dead space fraction, and greater physiologic shunt compared to those without hypoxaemia. These differences were replicated in a sensitivity analysis where patients with spirometric abnormalities were excluded. Regression analyses revealed that increases in pulmonary arterial and pulmonary capillary pressures were related to lower arterial oxygen tension (PaO2), especially during exercise. Body mass index (BMI) was not correlated with the arterial PaO2, and hypoxaemia was associated with increased risk for death over 2.8 (interquartile range 0.7-5.5) years of follow-up, even after adjusting for age, sex, and BMI (hazard ratio 2.00, 95% confidence interval 1.01-3.96; p=0.046) Conclusion Between 10% and 25% of patients with HFpEF display arterial desaturation during exercise that is not ascribable to lung disease. Exertional hypoxaemia is associated with more severe haemodynamic abnormalities and increased mortality. Further study is required to better understand the mechanisms and treatment of gas exchange abnormalities in HFpEF.
引用
收藏
页码:1593 / 1603
页数:11
相关论文
共 50 条
  • [1] Exercise hypoxaemia in heart failure with preserved ejection fraction
    Cohen-Solal, Alain
    Logeart, Damien
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (09) : 1604 - 1605
  • [2] HEART FAILURE IN PATIENTS WITH PRESERVED EJECTION FRACTION - PUMPING HEART FAILURE?
    Sokolov, A. A.
    Martsinkevich, G., I
    KARDIOLOGIYA, 2018, 58 (06) : 79 - 84
  • [3] Spironolactone in patients with heart failure and preserved ejection fraction
    Sanchez-Sanchez, C.
    Mendoza-Ruiz de Zuazu, H. F.
    Formiga, F.
    Manzano, L.
    Ceresuela, L. M.
    Carrera-Izquierdo, M.
    Gonzalez Franco, A.
    Epelde-Gonzalo, F.
    Cerqueiro-Gonzalez, J. M.
    Montero-Perez-Barquero, M.
    REVISTA CLINICA ESPANOLA, 2015, 215 (06): : 301 - 307
  • [4] Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
    Nanayakkara, Shane
    Patel, Hitesh C.
    Kaye, David M.
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2018, 12
  • [5] Treatment of patients with heart failure and preserved ejection fraction
    Deswal A.
    Bozkurt B.
    Current Treatment Options in Cardiovascular Medicine, 2008, 10 (6) : 516 - 528
  • [6] Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
    Poppe, Katrina K.
    Doughty, Robert N.
    HEART FAILURE CLINICS, 2014, 10 (03) : 503 - +
  • [7] Irbesartan in patients with heart failure and preserved ejection fraction
    Forman D.
    Gaziano J.M.
    Current Cardiovascular Risk Reports, 2009, 3 (5) : 311 - 312
  • [8] Spironolactone in patients with heart failure and preserved ejection fraction
    Nunez, J.
    Nunez, E.
    Sanchis, J.
    REVISTA CLINICA ESPANOLA, 2016, 216 (02): : 111 - 111
  • [9] Management of patients with heart failure and preserved ejection fraction
    Jasinska-Piadlo, Alicja
    Campbell, Patricia
    HEART, 2023, 109 (11) : 874 - 883
  • [10] Hypoxemia in patients with heart failure and preserved ejection fraction
    Omar, M.
    Omote, K.
    Sorimachi, H.
    Popovic, D.
    Kanwar, A.
    Alogna, A.
    Reddy, Y. N.
    Lim, K. G.
    Shah, S.
    Borlaug, B. B.
    EUROPEAN HEART JOURNAL, 2023, 44